Previous 10 | Next 10 |
Will The Names On This List Of Penny Stocks Rally Higher This Week? One of the most important things to keep in mind about penny stocks is that investors can make massive returns from only a small investment. On the other hand, that can work against investors as well. Since these stocks gene...
Gainers: NAVI +6.4% . NNVC +5.7%. IBM +4.3% . EXPR +4.1% . SPCE +3.1% . More news on: Navient Corporation, NanoViricides, Inc., International Business Machines Corporation, Stocks on the move, , Read more ...
Shares of TherapeuticsMD (NASDAQ: TXMD) , a commercial-stage biopharma focused on women's health, rose 16% as of 12:50 p.m. EST on Tuesday. The bullish move is most likely linked to the news that financial giant JP Morgan (NYSE: JPM) has taken a substantial equity positio...
Gainers : CSS Industries (NYSE: CSS ) +99% . More news on: CSS Industries, Inc., NanoViricides, Inc., Novavax, Inc., Stocks on the move, , Read more ...
Pfizer ( PFE +0.3% ) enters into a global license and collaboration agreement with eFFECTOR Therapeutics ( TXMD ) aimed at developing small molecule eukaryotic initiation factor 4E (eIF4E) inhibitors for the treatment of cancers with poor prognoses and resistance to certain therapies. Mo...
Our analysis concludes TXMD's operating cash burn, total and non-payroll related SG&A spending and seemingly unending dilution uncertainty has lead to continued share price losses. Our analysis concludes dilution is certain again in 2020 after TXMD lost a $50MM non-dilutive lender commitme...
Arrangement advances access to quality healthcare for women TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, and PlushCare, a virtual health platform that enables patients to book a virtual doctor’s appointment to get treatment, today announ...
SAN FRANCISCO , Jan. 7, 2020 /PRNewswire/ -- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, and PlushCare, a virtual health platform that enables patients to book a virtual doctor's appointment to get treatment, today announced that Therapeutic...
TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that the company will participate in the 38th Annual J.P. Morgan Healthcare Conference in San Francisco. Chief Executive Officer Robert G. Finizio will provide an overview of the company at t...
TherapeuticsMD (NASDAQ: TXMD ) and TPG Sixth Street Partners have amended the terms of the Company’s existing term loan financing facility to revise the draw trigger for one of the two $50M delayed draw loan tranches. More news on: TherapeuticsMD, Inc., Healthcare stocks news, ...
News, Short Squeeze, Breakout and More Instantly...
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Net Income (...
• Evaluation of strategic alternatives continues TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023...